FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378). Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S.142), Affordable Prescriptions for Patients Act (S.150). Block, Report, and Suspend Suspicious Shipments Act (H.R. 501). Proposals related to drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRYAN MICHAEL ALLEN New | Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Susan Collins (R-ME) |
| MEGAN SUSSMAN HERBER New | Press Secretary and Legislative Assistant, Rep. Christopher H. Smith (R-NJ) |
| ELLIOT VICE New | Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010 |
Copyright/Patent/Trademark CPT
Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378). Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S.142), Affordable Prescriptions for Patients Act (S.150). Block, Report, and Suspend Suspicious Shipments Act (H.R. 501). Proposals related to drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRYAN MICHAEL ALLEN New | Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Susan Collins (R-ME) |
| MEGAN SUSSMAN HERBER New | Press Secretary and Legislative Assistant, Rep. Christopher H. Smith (R-NJ) |
| ELLIOT VICE New | Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010 |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES, LTD. | Israel | Israel | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.